December 3rd, 2013
•These past 15 years, canine adenovirus type 2 (CAV2)-derived vectors have proven their efficiency to transduce cells in vitro and in vivo and are widely used for vaccination and gene therapy. Here, we describe a procedure to construct, produce and purify CAV2 vectors, giving rise to high-titer viral suspensions.
Tags
Video correlati
Trichuris muris Infection: A Model of Type 2 Immunity and Inflammation in the Gut
Production and Titering of Recombinant Adeno-associated Viral Vectors
Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems
Bone Marrow-derived Macrophage Production
Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
A Simple Fluorescence Assay for Quantification of Canine Neutrophil Extracellular Trap Release
Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Purification of High Yield Extracellular Vesicle Preparations Away from Virus
siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells